Skip to content

Clinical trials

Phase 1/2 Retinitis Pigmentosa trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinitis Pigmentosa Phase: Phase 1/2 Country / region: France Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20171
20181
20192
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Completed2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
SparingVision2
Allergan1
Centre d'Etude des Cellules Souches1
GenSight Biologics1
ProQR Therapeutics1
Sanofi1
eyeDNA Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinitis Pigmentosa8
Eye Diseases5
Retinal Degeneration4
Retinal Diseases4
Cone-Rod Dystrophies3
Eye Diseases, Hereditary3
Retinal Dystrophies3
Usher Syndromes2
Vision Disorders2
Eye Abnormalities1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.